Although several pharmacological like β blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, aldosterone antagonists, and nonpharmacological therapy options [136] have been introduced for the treatment of heart failure, mortality in heart failure patients remains high [137]. This evidence concerns the gene ACE and heart failure.